Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Leukemia Research|June 24, 2011
Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutationsHarshabad Singh, Salma Asali, Lillian L Werner, et al.
The Lancet. Haematology|March 31, 2019
An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 studyMichael R Savona, Olatoyosi Odenike, Philip C Amrein, et al.
Leukemia Research|June 19, 2013
Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)Eyal C Attar, Philip C Amrein, James W Fraser, et al.
Cancer|August 24, 2005
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinomaPhilip C Amrein, John R Clark, Jeffrey G Supko, et al.
Blood|December 2, 2004
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222Joseph O Moore, Stephen L George, Richard K Dodge, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathyA Loupy, A Cazes, R Guillemain, et al.
Cell|February 28, 2015
Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapyJoan Montero, Kristopher A Sarosiek, Joseph D DeAngelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2011
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemiaPhilip C Amrein, Eyal C Attar, Tak Takvorian, et al.
The Lancet. Haematology|June 7, 2016
Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysisAreej El-Jawahri, Tanya Keenan, Gregory A Abel, et al.
Blood Advances|January 7, 2020
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangementValentina Nardi, Nora Ku, Matthew J Frigault, et al.
Pageof 10